Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -98,404 | -66,761 | -33,709 | -94,260 | -68,634 |
| Accounts receivable | -17,243 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -3,184 | -3,582 | -625 | 2,807 | -235 |
| Other Working Capital | -13,975 | -9,702 | -3,115 | 5,547 | -673 |
| Other Operating Activity | 30,435 | 9,969 | 3,431 | 4,694 | 5,692 |
| Operating Cash Flow | $-102,371 | $-70,076 | $-34,018 | $-81,212 | $-63,850 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 139,418 | 87,165 | 28,583 | -191,538 | -187,821 |
| PPE Investments | -590 | -590 | N/A | -325 | -325 |
| Investing Cash Flow | $138,828 | $86,575 | $28,583 | $-191,863 | $-188,146 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3 | 0 | 0 | 157,202 | 157,202 |
| Financing Cash Flow | $3 | $0 | $0 | $157,202 | $157,202 |
| Beginning Cash Position | 59,820 | 59,820 | 59,820 | 175,693 | 175,693 |
| End Cash Position | 96,280 | 76,319 | 54,385 | 59,820 | 80,899 |
| Net Cash Flow | $36,460 | $16,499 | $-5,435 | $-115,873 | $-94,794 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,371 | -70,076 | -34,018 | -81,212 | -63,850 |
| Capital Expenditure | -590 | -590 | N/A | -325 | -325 |
| Free Cash Flow | -102,961 | -70,666 | -34,018 | -81,537 | -64,175 |